Evidence map›Paper›PMID 29052924›Full record

ReviewRespirology (Carlton, Vic.)2018

MERS, SARS and other coronaviruses as causes of pneumonia.

Yudong Yin, Richard G Wunderink

3 registry-linked trialsOpen access · greenAbstract readReview
In one paragraph

Review in Respirology (Carlton, Vic.), 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to 3 registered trials, which are not on this map. Cited by 519 papers, 7 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
519citing papers in PubMed, 7 pooled it
90.3field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT04441502 unknown statusnot on this mapstarted 2020, after this paper: background citation

Identification of Predictors for the Evolution of COVID-19 Related Interstitial Pneumonia by Transcriptomic and Seroproteomic Techniques

TypeobservationalSponsorIRCCS Policlinico S. DonatoRan2020 to 2024Enrolled204ConditionsCovid19, Interstitial Pneumonia
NCT04485364 completednot on this mapstarted 2020, after this paper: background citation

Place of Circulating Biomarkers and Respiratory Eicosanoids in the Prognosis of Severe Forms of Covid-19 Pneumonia: BioCovid Study

TypeobservationalSponsorFondation Hôpital Saint-JosephRan2020 to 2022Enrolled97ConditionsCoronavirus, Covid19
NCT05017441 unknown statusnot on this mapstarted 2021, after this paper: background citation

TOcilizumab and Covid-19 : Risk of Severe INfection

TypeobservationalSponsorFondation Hôpital Saint-JosephRan2021 to 2024Enrolled1,200ConditionsCovid19
3 · Its place in the literature

Who cites it

519 citing papers in PubMed, 7 syntheses or guidelines pooled it, 1,134 citations in OpenAlex.

  1. Impact of air pollution on COVID-19 severity: a systematic review of underlying biological mechanisms.European respiratory review : an official journal of the European Respiratory Society · 2025
    Pooled it
  2. Pooled it
  3. Pooled it
  4. Potential ofBioMed research international · 2022
    Pooled it
  5. Pooled it
  6. Clinical and laboratory findings of COVID-19: A systematic review and meta-analysis.Journal of the Formosan Medical Association = Taiwan yi zhi · 2021
    Pooled it
  7. Pooled it
  8. Article
  9. Article
  10. Article
  11. Review
  12. Article
  13. Article
  14. Article
  15. Coinfection ofFrontiers in cellular and infection microbiology · 2025
    Article
  16. Article
  17. Article
  18. Article
  19. Observational
  20. Review

459 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors at 2 institutions in 2 countries.

Yudong YinDepartment of Infectious Diseases and Clinical Microbiology, Beijing Chao-Yang Hospital, Capital Medical University, Beijing, China.
Richard G WunderinkDivision of Pulmonary and Critical Care, Department of Medicine, Northwestern University Feinberg School of Medicine, Chicago, Illinois, USA.ORCID 0000-0002-8527-4195
Capital Medical University · CNNorthwestern University · US

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Human coronaviruses (HCoVs) have been considered to be relatively harmless respiratory pathogens in the past. However, after the outbreak of the severe acute respiratory syndrome (SARS) and emergence of the Middle East respiratory syndrome (MERS), HCoVs have received worldwide attention as important pathogens in respiratory tract infection. This review focuses on the epidemiology, pathogenesis and clinical characteristics among SARS-coronaviruses (CoV), MERS-CoV and other HCoV infections.

Indexed as

Coronavirus InfectionsHumansMiddle East Respiratory Syndrome CoronavirusPneumonia, ViralSevere Acute Respiratory SyndromeSevere acute respiratory syndrome-related coronavirushuman coronavirusesMiddle East respiratory syndromepneumoniasevere acute respiratory syndrome

Identifiers

PMID29052924
PMCPMC7169239
OpenAlexW2766931063

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.